Icon

FOTIVDA (nda212904)- (EQ 0.89MG BASE,EQ 1.34MG BASE)

TIVOZANIB HYDROCHLORIDE AVEO PHARMS
EQ 0.89MG BASE,EQ 1.34MG BASE
No No
2039-Nov-05 2026-Mar-10
None None
None No
FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
0 0 0
Total Other Developers 4
Drugs with Suitability No
EQ 0.89MG BASE ** ** - - -
EQ 1.34MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.